
Graphene Trace aims to eliminate pressure ulcers through smart, accessible preventative technology utilizing graphene and AI. Their core product is a smart pressure sensing fabric that continuously monitors pressure distribution. It alerts users when and how to reposition themselves to prevent the development of pressure ulcers. The technology is designed to be comfortable, affordable, highly sensitive, and offers high resolution for continuous and automated prevention. Graphene Trace's solution transforms pressure mapping from a specialized clinical tool into an everyday solution, providing unique data insights and AI-driven smart alerts for personalized repositioning guidance. Their flexible sensor mat is compatible with various seating surfaces and beds, offering peace of mind, improved quality of care, and potentially saving lives by addressing a critical issue in healthcare, particularly in care homes.

Graphene Trace aims to eliminate pressure ulcers through smart, accessible preventative technology utilizing graphene and AI. Their core product is a smart pressure sensing fabric that continuously monitors pressure distribution. It alerts users when and how to reposition themselves to prevent the development of pressure ulcers. The technology is designed to be comfortable, affordable, highly sensitive, and offers high resolution for continuous and automated prevention. Graphene Trace's solution transforms pressure mapping from a specialized clinical tool into an everyday solution, providing unique data insights and AI-driven smart alerts for personalized repositioning guidance. Their flexible sensor mat is compatible with various seating surfaces and beds, offering peace of mind, improved quality of care, and potentially saving lives by addressing a critical issue in healthcare, particularly in care homes.
Sector: Medtech — pressure-ulcer prevention
Core product: Graphene-enabled smart pressure-sensing fabric with AI-driven repositioning alerts
Headquarters: Wickford, Essex, United Kingdom
Founders: Scott Dean; Christopher Castle
Team size: ~5 employees
Recent funding: Pre-seed round announced 2025-03-31
Prevention of pressure ulcers (pressure injury) in wheelchair users, care-home residents, and hospital patients.
Medical devices / health technology
Pre-seed round announced March 31, 2025; Crunchbase lists SFC Capital as investor. Public pages obfuscate exact amount for the round.
“SFC Capital; Innovate UK”